Cargando…

Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha)

Detalles Bibliográficos
Autores principales:	Xia, Shuai, Wen, Zuoling, Wang, Lijue, Lan, Qiaoshuai, Jiao, Fanke, Tai, Linhua, Wang, Qian, Sun, Fei, Jiang, Shibo, Lu, Lu, Zhu, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576028/ https://www.ncbi.nlm.nih.gov/pubmed/34750362 http://dx.doi.org/10.1038/s41421-021-00349-z

Ejemplares similares

25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses
por: Lan, Qiaoshuai, et al.
Publicado: (2021)

Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
por: Lan, Qiaoshuai, et al.
Publicado: (2021)

A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern
por: Lan, Qiaoshuai, et al.
Publicado: (2022)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
por: Xia, Shuai, et al.
Publicado: (2020)

Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation
por: Xia, Shuai, et al.
Publicado: (2021)

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
por: Zárate, Selene, et al.
Publicado: (2022)

Revisiting the association between temperature and COVID-19 transmissibility across 117 countries
por: Chen, Simiao, et al.
Publicado: (2020)

Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people
por: Brookman, Sarah, et al.
Publicado: (2021)

The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out
por: Giles, Benjamin, et al.
Publicado: (2021)

SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
por: Xia, Shuai, et al.
Publicado: (2023)

Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
por: Michaelsen, Thomas Y., et al.
Publicado: (2022)

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia, et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia R., et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

The Dominance of Ossicular Route in Sound Transmission
por: Zakaria, Mohd Normani, et al.
Publicado: (2016)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine
por: Nasereddin, Abedelmajeed, et al.
Publicado: (2022)

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
por: Xia, Shuai, et al.
Publicado: (2022)

In Reply: Dominance of Ossicular Route in Sound Transmission
por: Park, Hanaro, et al.
Publicado: (2016)

Development of oncolytic virotherapy: from genetic modification to combination therapy
por: Lan, Qiaoshuai, et al.
Publicado: (2020)

Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
por: Zhang, Jingsong, et al.
Publicado: (2021)

Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England
por: Vusirikala, Amoolya, et al.
Publicado: (2022)

Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants
por: van Ogtrop, M. L., et al.
Publicado: (2021)

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual
por: Kernéis, Solen, et al.
Publicado: (2021)

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020)

A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life
por: Duan, Qianyu, et al.
Publicado: (2022)

The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants
por: Pu, Jing, et al.
Publicado: (2022)

Probable vertical transmission of Alpha variant of concern (B.1.1.7) with evidence of SARS-CoV-2 infection in the syncytiotrophoblast, a case report
por: Bullock, Hannah A., et al.
Publicado: (2023)

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, Kyle, et al.
Publicado: (2021)

A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses
por: Cai, Yanxing, et al.
Publicado: (2021)

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach
por: Carcereny, Albert, et al.
Publicado: (2022)

Epidemiological and molecular description of nosocomial outbreak of COVID-19 Alpha (B.1.1.7) variant in Saudi Arabia
por: Alsaedi, Asim, et al.
Publicado: (2022)

Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

First Report of SARS-CoV-2 Lineage B.1.1.7 (Alpha Variant) in Ecuador, January 2021
por: Carrazco-Montalvo, Andres, et al.
Publicado: (2021)

COVID‐19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID‐19 pediatric convalescents
por: Gurevich, Michael, et al.
Publicado: (2022)

Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
por: Xia, Shuai, et al.
Publicado: (2019)

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
por: Xia, Shuai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82hpgto60rc6ageevnf67iuh78